Data on the first experience of insulin degludec (Tresiba®) treatment for type 2 diabetes in daily clinical practice

Data on the first experience of insulin degludec (Tresiba®) treatment for type 2 diabetes in daily clinical practice

Aim: The aim of this study was to evaluate the efficacy and safety of the new ultra-long-acting insulin degludec (Tresiba®) in the treatment of type 2 diabetes in routine clinical practice.Methods: This primary health care clinical observational study included 20 insulin-naïve type 2 diabetic patien...

Full description

Bibliographic Details
Main Authors: Lyudmila Alexandrovna Suplotova, Nikolay Valer'evich Plotnikov, Natal'ya Valer'yanovna Romanova, Larisa Nikolaevna Bel’chikova, Ekaterina Viktorovna Khieva, Marina Vladimirovna Shestakova
Format: Article
Language:English
Published: Endocrinology Research Centre 2015-12-01
Series:Сахарный диабет
Subjects:
type 2 diabetes mellitus
insulin degludec
glycaemic control
hypoglycaemia
quality of life
Online Access:https://www.dia-endojournals.ru/jour/article/view/7695

Internet

https://www.dia-endojournals.ru/jour/article/view/7695

Similar Items